Please use this identifier to cite or link to this item:
http://hdl.handle.net/11375/31476
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Bhuiya, AR | - |
dc.contributor.author | Wilson, MG | - |
dc.contributor.author | Moat, KA | - |
dc.contributor.author | Gauvin, François-Pierre | - |
dc.contributor.author | Wang, Q | - |
dc.contributor.author | Whitelaw, S | - |
dc.contributor.author | Alam, S | - |
dc.contributor.author | Sharma, K | - |
dc.contributor.author | Ahmad, A | - |
dc.contributor.author | Drakos, A | - |
dc.contributor.author | Dren, N | - |
dc.contributor.author | Bain, T | - |
dc.contributor.author | Lavis, JN | - |
dc.date.accessioned | 2025-04-09T18:28:07Z | - |
dc.date.available | 2025-04-09T18:28:07Z | - |
dc.date.issued | 2020-11 | - |
dc.identifier.citation | Bhuiya AR, Wilson MG, Moat KA, Gauvin FP, Wang Q, Whitelaw S, Alam S, Sharma K, Ahmad A, Drakos A, Dren N, Bain T, Lavis JN. COVID-19 rapid evidence profile #23: What is known about anticipated COVID-19 vaccine-delivery program elements, and whether and how federated states are harmonizing these elements across constituent units of federations. Hamilton: McMaster Health Forum, 5 November 2020. | en_US |
dc.identifier.uri | http://hdl.handle.net/11375/31476 | - |
dc.description.abstract | An overview of the best available research evidence from around the world (i.e., evidence syntheses) and local research evidence (i.e., single studies) and may include a scan of experiences from other countries and from Canadian provinces and territories, about anticipated COVID-19 vaccine-delivery program elements, and whether and how federated states are harmonizing these elements across constituent units of federations in response to a decision-maker’s request. | en_US |
dc.description.sponsorship | The McMaster Health Forum is one of the three co-leads of RISE, which is supported by a grant from the Ontario Ministry of Health to the McMaster Health Forum. | en_US |
dc.language.iso | en | en_US |
dc.relation.ispartofseries | REP 23; | - |
dc.subject | COVID-19 | en_US |
dc.subject | vaccine-delivery | en_US |
dc.subject | program | en_US |
dc.subject | federations | en_US |
dc.subject | states | en_US |
dc.title | COVID-19 rapid evidence profile #23: What is known about anticipated COVID-19 vaccine-delivery program elements, and whether and how federated states are harmonizing these elements across constituent units of federations? | en_US |
Appears in Collections: | Rapid evidence profiles |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
covid-19-rep-23_vaccine-delivery-programs_2020-11-06_final.pdf | 665.42 kB | Adobe PDF | View/Open |
This item is licensed under a Creative Commons License